Novel serine protease inhibitory protein mt0039
CA 2459272 A1 · Owner: Shinozaki, Mikihiko · Inventors: Hosaka, Yoshitaka; Nanba, Mutsuo; Shinozaki, Mikihiko
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
It is intended to provide a gene and a protein participating in the control of serine protease activity and a method of efficiently evaluating an activity controlling agent for the protein. DNA having the base sequence represented by SEQ ID NO:1; a serine protease inhibitory protein encoded by the above DNA; a method of searching for a substance binding to the above protein with the use of the protein; an antisense nucleic acid to the above DNA; and an antibody specific to the above protein.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 3, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 3, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 3, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.